126 related articles for article (PubMed ID: 33116758)
1. Comprehensive Evaluation of Endocytosis-Associated Protein SCAMP3 in Hepatocellular Carcinoma.
Zhou A; Liu H; Tang B
Pharmgenomics Pers Med; 2020; 13():415-426. PubMed ID: 33116758
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Analysis and RNA-Sequencing of SCAMP3 Expression and Correlated Gene Regulation in Hepatocellular Carcinoma.
Han SS; Feng ZQ; Liu R; Ye J; Cheng WW; Bao JB
Onco Targets Ther; 2020; 13():1047-1057. PubMed ID: 32099407
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma.
Zhang X; Sheng J; Zhang Y; Tian Y; Zhu J; Luo N; Xiao C; Li R
Oncotarget; 2017 Dec; 8(65):109247-109257. PubMed ID: 29312605
[TBL] [Abstract][Full Text] [Related]
4. SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR-MAPK p38 signaling pathway.
Kang L; Zhang ZH; Zhao Y
Am J Transl Res; 2020; 12(12):7870-7884. PubMed ID: 33437366
[TBL] [Abstract][Full Text] [Related]
5. SCAMP3 Promotes Glioma Proliferation and Indicates Unfavorable Prognosis via Multiple Pathways.
Li C; Zhang Z; Lv P; Zhan Y; Zhong Q
Onco Targets Ther; 2020; 13():3677-3687. PubMed ID: 32431518
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiation.
Naboulsi W; Bracht T; Megger DA; Reis H; Ahrens M; Turewicz M; Eisenacher M; Tautges S; Canbay AE; Meyer HE; Weber F; Baba HA; Sitek B
Biochim Biophys Acta; 2016 Nov; 1864(11):1579-85. PubMed ID: 27519163
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.
Zhang Q; Liu XJ; Li Y; Ying XW; Chen L
Technol Cancer Res Treat; 2021; 20():15330338211011966. PubMed ID: 34159865
[TBL] [Abstract][Full Text] [Related]
12. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
Chen S; Zhang Y; Ding X; Li W
Front Genet; 2022; 13():838869. PubMed ID: 35386284
[No Abstract] [Full Text] [Related]
13. High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma.
Huang X; Zhu S; Zhang K; Tan W; Chen Y; Shang C
Front Mol Biosci; 2022; 9():814058. PubMed ID: 35141283
[No Abstract] [Full Text] [Related]
14. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
16. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
18. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Wu Z; He L; Yang L; Fang X; Peng L
Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
[No Abstract] [Full Text] [Related]
19. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
Zhang X; Xu S; Hu C; Fang K; Zhou J; Guo Z; Zhu G; Li L
Biochem Biophys Res Commun; 2020 Dec; 533(4):1039-1047. PubMed ID: 33012505
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
[Next] [New Search]
